NCT06003348View on ClinicalTrials.gov

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

PHASE4RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

May 31, 2028

Study Completion Date

August 31, 2028

Conditions
Calcium Phosphate Kidney Stones
Interventions
DIETARY_SUPPLEMENT

OHCit- standard dose

Hydroxycitrate Over-the-counter supplement, not FDA approved or regulated.

DRUG

Potassium Citrate

10 mEq Extended-release tablets for oral use

DRUG

Placebo

Placebo

DIETARY_SUPPLEMENT

OHCit- low dose

Hydroxycitrate Over-the-counter supplement, not FDA approved or regulated.

Trial Locations (1)

75390-8885

RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER